Cargando…
NICE technology appraisals: working with multiple levels of uncertainty and the potential for bias
One of the key roles of the English National Institute for Health and Clinical Excellence (NICE) is technology appraisal. This essentially involves evaluating the cost effectiveness of pharmaceutical products and other technologies for use within the National Health Service. Based on a content analy...
Autores principales: | Brown, Patrick, Calnan, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617347/ https://www.ncbi.nlm.nih.gov/pubmed/22198480 http://dx.doi.org/10.1007/s11019-011-9376-2 |
Ejemplares similares
-
Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
por: Hashem, Ferhana, et al.
Publicado: (2017) -
Temporal uncertainty in disease diagnosis
por: Hofmann, Bjørn
Publicado: (2023) -
The impact of rarity in NICE’s health technology appraisals
por: Clarke, Sophie, et al.
Publicado: (2021) -
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
por: Dickson, Rumona, et al.
Publicado: (2018) -
Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012)